H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Mar Drugs. 2023 Sep 26;21(10):510. doi: 10.3390/md21100510.
Marine natural products are well-recognized as potential resources to fill the pipeline of drug leads to enter the pharmaceutical industry. In this circumstance, marine-derived fungi are one of the unique sources of bioactive secondary metabolites due to their capacity to produce diverse polyketides and peptides with unique structures and diverse biological activities. The present review covers the peptides from marine-derived fungi reported from the literature published from January 1991 to June 2023, and various scientific databases, including Elsevier, ACS publications, Taylor and Francis, Wiley Online Library, MDPI, Springer, Thieme, Bentham, ProQuest, and the Marine Pharmacology website, are used for a literature search. This review focuses on chemical characteristics, sources, and biological and pharmacological activities of 366 marine fungal peptides belonging to various classes, such as linear, cyclic, and depsipeptides. Among 30 marine-derived fungal genera, isolated from marine macro-organisms such as marine algae, sponges, coral, and mangrove plants, as well as deep sea sediments, species of were found to produce the highest number of peptides (174 peptides), followed by (23 peptides), (22 peptides), (18 peptides), (18 peptides), (17 peptides), and (12 peptides). The cytotoxic activity against a broad spectrum of human cancer cell lines was the predominant biological activity of the reported marine peptides (32%), whereas antibacterial, antifungal, antiviral, anti-inflammatory, and various enzyme inhibition activities ranged from 7% to 20%. In the first part of this review, the chemistry of marine peptides is discussed and followed by their biological activity.
海洋天然产物被公认为是潜在的药物先导化合物资源,可以进入制药行业。在这种情况下,海洋来源的真菌是具有生物活性的次级代谢产物的独特来源之一,因为它们能够产生具有独特结构和多种生物活性的多样聚酮和肽。本综述涵盖了 1991 年 1 月至 2023 年 6 月期间文献中报道的海洋来源真菌来源的肽,以及各种科学数据库,包括爱思唯尔、ACS 出版物、泰勒弗朗西斯、Wiley Online Library、MDPI、施普林格、蒂梅、本瑟姆、ProQuest 和 Marine Pharmacology 网站,用于文献检索。本综述重点介绍了 366 种海洋真菌肽的化学特性、来源以及生物和药理学活性,这些肽属于各种类别,如线性、环状和去肽。在 30 种海洋来源的真菌属中,从海洋大型生物如海洋藻类、海绵、珊瑚和红树林植物以及深海沉积物中分离出来的种属产生了数量最多的肽(174 种肽),其次是 (23 种肽)、 (22 种肽)、 (18 种肽)、 (18 种肽)、 (17 种肽)和 (12 种肽)。对广泛的人类癌细胞系的细胞毒性活性是报道的海洋肽的主要生物学活性(32%),而抗菌、抗真菌、抗病毒、抗炎和各种酶抑制活性范围为 7%至 20%。在本综述的第一部分中,讨论了海洋肽的化学性质,然后是它们的生物学活性。